GlassScriptPhysician profile
Elizabeth Kidder
NPI 1407276587
$4,518.16
in general payments reported to CMS, 2019-2025
41 companies · $935 in 2025
The $935 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $219 · 2021: $345 · 2022: $342 · 2023: $1,032 · 2024: $1,222 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,130 · Long Term Medical Supply Or Device Loan: $49.95 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,130.46 |
| Long Term Medical Supply Or Device Loan | $49.95 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $798.23 | 2019-2025 | Descovy |
| Glaxosmithkline, LLC. | $573.66 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $453.64 | 2020-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $316.53 | 2020-2025 | |
| Novartis Pharmaceuticals Corporation | $233.53 | 2023-2024 | |
| Amgen INC. | $232.95 | 2019-2024 | Prolia, Repatha, Evenity |
| Merck Sharp & Dohme LLC | $196.83 | 2019-2025 | Gardasil 9, Capvaxive, Gardasil |
| Pfizer INC. | $183.78 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $180.93 | 2022-2025 | Spravato |
| Exact Sciences Corporation | $104.91 | 2023-2025 | Cologuard Collection Kit |
| Alkermes, INC. | $104.44 | 2019-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $91.54 | 2019-2025 | |
| Lilly USA, LLC | $90.81 | 2019-2025 | Mounjaro, Zepbound |
| Braeburn INC. | $90.08 | 2024-2025 | Brixadi |
| Abbott Laboratories | $72.52 | 2025 | Freestyle Insulinx, Freestyle Libre 3 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $56.99 | 2022-2025 | Sublocade |
| Teva Pharmaceuticals USA, INC. | $53.87 | 2023-2025 | Austedo Xr, Austedo Xr, Uzedy |
| Astellas Pharma US INC | $53.73 | 2024 | Veozah |
| Otsuka America Pharmaceutical, INC. | $52.31 | 2023-2025 | Rexulti |
| Baxter Healthcare | $48.75 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Phathom Pharmaceuticals, INC. | $46.72 | 2024-2025 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $40.75 | 2022 | |
| Hologic Sales and Service, LLC | $39.25 | 2024 | Aptima |
| Ironshore Pharmaceuticals INC. | $38.79 | 2024 | |
| Corium, LLC | $34.11 | 2024 | Azstarys |
| Organon LLC | $32.95 | 2021 | |
| Exeltis, USA INC. | $32.12 | 2023-2025 | Slynd |
| Sanofi-Aventis U.S. LLC | $28.12 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $25.92 | 2023 | Gemtesa |
| Dexcom, INC. | $23.40 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $22.61 | 2023 | Gvoke Hypopen |
| Viiv Healthcare Company | $21.77 | 2025 | Cabenuva |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2022 | |
| Collegium Pharmaceutical, INC. | $20.54 | 2025 | Jornay Pm |
| Daiichi Sankyo INC. | $19.39 | 2021 | |
| Insulet Corporation | $17.30 | 2024 | Omnipod |
| Boston Scientific Corporation | $16.76 | 2025 | Watchman Flx |
| Axsome Therapeutics, INC. | $16.47 | 2024 | Auvelity |
| Sanofi Pasteur INC. | $16.26 | 2020 | |
| Redhill Biopharma INC. | $14.20 | 2025 | Talicia |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Kidder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.